Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VTRS
#613
Viatris Inc. - Common Stock
16.8
9
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.24%
Monthly Change
-5.96%
6 month change
+13.13%
Year Change
+63.19%
Previous Close
16.8
5
Open
16.8
9
Low
16.8
9
High
16.8
9
Volume
192
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
VTRS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
2024
Current report, Q3 FY2024
2024.08.08
Viatris Inc current report, Q3 FY2024
8-K
Current report, Q3 FY2024
2024.07.03
Viatris Inc current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.08.08
Viatris Inc quarterly report, Q2 FY2024
10-Q
1
2
3
4
News
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Here's Why Viatris (VTRS) is a Strong Value Stock
Tracking Christopher Davis’ Davis Selected Advisers 13F Portfolio: Q2 2026 Update (DUSA)
Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
CVS Health (CVS) Q2 Earnings and Revenues Beat Estimates
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?